Using a rat model of cerebral ischemia, Wang et al. reported that the Jak2 inhibitor AG490 could improve neurological deficits, cerebral infarction, edema, oxidative stress, and inflammation (Wang et al., 2021). The gene discussed is JAK2; the disease is cerebral infarction.